Clinical Trial Update: A First-in-human Study of PRTH-101 Monotherapy +/- Pembrolizumab in Subjects With Advanced Malignancies [Phase 1]

View source ↗

Summary

A first-in-human Phase 1 study of PRTH-101 alone or with pembrolizumab in patients with advanced malignancies is recruiting, including non-small cell lung cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• PRTH-101

Snippet

Sponsor: Incendia Therapeutics | Conditions: Advanced or Metastatic Solid Tumors, Non Small Cell Lung Cancer | Phase 1 | Status: RECRUITING